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ABSTRACT  We investigated  the whole cell distribution of the platelet membrane receptor for 
fibrinogen in surface-activated human platelets.  Fibrinogen-labeled colloidal gold was used in 
conjunction  with  platelet  whole  mount  preparations  to  visualize  directly  the  fibrinogen 
receptor. Unstimulated platelets  fail to bind fibrinogen, and binding was minimal  in the stages 
of activation  immediately  following adhesion. The amount of fibrinogen  bound  per platelet 
increased  rapidly during the shape changes associated  with  surface  activation  until  7,600 _+ 
500 labels were present at saturation. Maximal binding of fibrinogen was followed by receptor 
redistribution.  During the early stages of spreading,  fibrinogen  labels were uniformly  distrib- 
uted over the entire platelet surface,  including pseudopodia, but the labels become progres- 
sively  centralized  as the spreading  process  continued.  In well  spread  platelets,  labels  were 
found over the central regions, whereas peripheral areas were cleared of receptors. Receptor 
redistribution during spreading was accompanied  by cytoskeletal  reorganization such  that a 
direct correlation was seen between the development of specific ultrastructural zones and the 
distribution of surface  receptor sites suggesting a link between the surface  receptors and the 
cytoskeleton. The association  of fibrinogen  receptors with  contractile elements of the cyto- 
skeleton, which permits coordinated receptor centralization, is important to the understanding 
of the role of fibrinogen in normal platelet aggregation  and clot retraction. 
Platelet aggregation is essential for normal hemostasis. Recent 
investigations  have  indicated  there  is  a  strong  correlation 
between fibrin0gen binding to activated platelets and aggre- 
gation (9,  30,  37, 45, 47). Fibrinogen is a required co-factor 
in platelet aggregation induced by ADP, since suspensions of 
gel-filtered  or  washed  human  platelets  fail  to  aggregate  in 
response to ADP in the absence of fibrinogen (9, 21, 29, 33). 
Further evidence for a  role of fibrinogen in  aggregation is 
illustrated by the observation that platelets in citrated plasma 
from afibrinogenemic patients aggregate  poorly in response 
to ADP  and  epinephrine (19,  48,  49).  The mechanism  by 
which fibrinogen mediates platelet aggregation is unknown, 
but it is most likely a function of the association of fibrinogen 
with the platelet surface, since aggregation involves the surface 
membranes of adjacent platelets (30, 49). The direct associa- 
tion of fibrinogen with  specific  membrane glycoproteins is 
supported by studies with platelets from Glanzmann's throm- 
basthenia. Platelet membrane glycoproteins lib (GPIIb) and 
Ilia (GPIIIa) are markedly diminished in this inherited bleed- 
ing disorder (39),  and  platelets from these patients do not 
bind fibrinogen and do not aggregate  (3,  8, 22,  31). Recent 
studies by Marguerie and  co-workers (24,  25),  Bennet and 
Vilaire (3), and Plow and Marguerie (4 l) have confirmed that 
fibrinogen binds  to  specific saturable  receptor sites  on the 
platelet membrane. In these studies,  using radiolabeled fibrin- 
ogen, binding is not detectable on unstimulated platelets, but 
fibrinogen binding is induced by activation with ADP and 
epinephrine. Peerschke et al. (37) showed binding of radiola- 
beled fibrinogen to activated platelets correlates well with the 
time course of ADP-induced aggregation.  The interaction of 
fibrinogen with its membrane receptor has been characterized 
with regard to the effects of  temperature, pH, and the require- 
ment  for divalent cations (26).  Association constants have 
been estimated by Scatchard plot analysis of saturable binding 
curves (3, 24, 26, 37, 41). 
In this study, we report the use of fibrinogen-labeled colloi- 
dal gold (FGN-Au)  1 to visualize directly the human platelet 
membrane  receptor for fibrinogen  by  scanning  and  high- 
Abbreviations used in this paper:  FGN-Au,  fibrinogen-labeled  col- 
loidal gold; HVEM, high-voltage electron microscopy; PHEM, 60 
mM PIPES, 25 mM HEPES, 10 mM EGTA, and 2 mM MgCI~. 
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in the whole cell distribution of the fibrinogen receptor cor- 
relate with the cytoskeletal reorganization that accompanies 
the shape change or spreading process that platelets exhibit in 
response to a variety of stimuli including an artificial surface. 
The results  support  an  association  between  the  fibrinogen 
receptor and the cytoskeleton and provide additional insight 
into the possible mechanisms of action of fibrinogen in plate- 
let aggregation and clot retraction. 
MATERIALS  AND  METHODS 
Preparation of Colloidal Gold:  A stock solution  of colloidal  gold 
granules  having  an  average diameter  of 18  nm were prepared  by reducing 
HAuCL with trisodium  citrate  (12-14,  17). A 4% solution  of HAuCI.4 (0.5 
ml) was added to 200 ml of deionized distilled water and brought to a boil. A 
freshly prepared solution  of 1% trisodium  citrate (5 ml) was rapidly added to 
the boiling solution and the mixture refluxed for 30 min. The formation of the 
monodisperse  colloidal  particles  was indicated  by a  clark blue  to red  color 
change. The colloidal solution was cooled, filtered through a microporous filter 
(Millipore  Millex-GS 0.22-#m  filter  unit),  and  stored  at  4"C  under sterile 
conditions. 
Preparation of Fibrinogen, Fibrinogen-Cold, and Antibody- 
Gold Complexes:  Fibrinogen was a gift of  Dr. Dcane Mosher  (University 
of  Wisconsin). It was purified from fresh human citrated plasma by precipitation 
with 25% saturated  ammonium sulfate followed by DEAE-cellulose chroma- 
tography (28). The final product was dialyzed against 0.01 M Tris and 0.14 M 
NaCl, pH 7.4 Aliquots of 10-15 mg/ml were stored at -70"C. 
Absorption  isotherms 03,  16) were performed to determine  the minimum 
amount of fibrinogen necessary to stabilize the colloidal gold. Previous inves- 
tigations have indicated that optimum absorption  occurs at or slightly basic to 
the pl of the protein.  The gold solution  was adjusted  to pH 6.5  with 0.2 N 
K:CO3 as  measured  by gel-filled combination electrode  (No.  9115, Orion 
Research, Inc., Cambridge, MA). A series of fibrinogen solutions of increasing 
concentration  were made up to l ml and added to 5 ml of colloidal gold. After 
1 min at room temperature,  l  ml of 10%  NaG1 solution  was added  to the 
fibrinogen-gold. Inadequate  stabilization  of the colloid results in flocculation 
of the gold granules with flocculation indicated by a color change from red to 
blue, which can be judged  visually or spectrophotometrically.  The minimum 
amount of fibrinogen necessary to prevent  flocculation was 8 pg/mg of gold 
solution. 
l0 ml of gold solution  (pH 6.5) was added  to a  10%  excess of dialyzed 
fibrinogen (0.005 M NaCl) and mixed by gentle inversion. After 5 min at room 
temperature,  0.5  ml of freshly prepared  and prefiltered (Millipore 0.45 pm) 
polyethylene glycol 20,000 mol wt was added to prevent aggregation. The FGN- 
Au  was concentrated  and  excess  fibrinogen  removed  by  centrifugation  in 
polycarbonate  tubes at 10,000 rpm for 30 min. The superuate  was discarded, 
and the concentrated  red pool was resuspended  to  l  ml with sterile filtered 
(Millipore 0.2 tzm) protein-free Tyrodes buffer supplemented with l mM Ca ++. 
The monoclonal antibody  10E5, which is directed  against the GPIIb-IIIa 
receptor complex, was a gift from Dr. Barry Coller (State University of New 
York at Stonybrook  Health Sciences Center). The specificity of 10E5 has been 
fully characterized in a previous report (7). The minimum amount of antibody 
necessary to stabilize the gold particles was determined by absorption isotherms 
as described  above.  After conjugation  and centrifugation,  the antibody-gold 
complex (10E5-Au) was resuspended to 1 ml with sterile filtered (Millipore 0.2 
/zm) 0. l M phosphate buffer; pH 7.4. 
Platelet Preparation and Gold labeling:  Plateletswereobtained 
from normal healthy adult  volunteers by venous puncture.  Blood samples (10 
ml) were collected in polypropylene tubes containing  10 mM EGTA and mixed 
by gentle  inversion.  Platelet-rich  plasma was prepared  by centrifugation  of 
whole blood at 180 g for l0 min at room temperature.  Platelets were separated 
from plasma proteins  by passage through a  Sepharose  CI-2B column (46) 
having a 40-ml bed volume. The volume was equilibrated at room temperature 
with a calcium-free Tyrode's buffer, pH 7.3 (136 mM NaO, 2.7 mM KCI, 0.42 
mM NaH2PO4, 12 mM NaHCO3, 2 mM MgCI2, l g/liter dextrose and 2 g/liter 
albumin). Platelets were collected in the void volume and deposited on Formvar 
filmed Ni maxtiform grids and allowed to settle and adhere at 37°C in a moist 
chamber. The extent of  spreading was monitored by phase-contrast microscopy, 
and at various  stages of spreading,  grids containing  adherent  platelets were 
removed  and  washed  with  protein-free  buffer.  The  time  frame  for platlet 
spreading after surface activation has been well documented (2). From the time 
of contact  with the Formvar film, the entire spreading process requires ~ 12- 
15 min. Maximum incubation  time was 20 min. 
Platelet  cytoskeletons  were  prepared  by  previously  described  extraction 
procedures (43). The extraction  buffer, PHEM, consistedof 60 mM PIPES, 25 
mM HEPES,  l0 mM EGTA, and 2 mM MgCl2. Well spread platelets were 
washed with  PHEM  buffer then lysed with 0.15% Triton X-100  in PHEM 
buffer for l  min. Grids were thoroughly  washed in buffer and prepared  for 
electron microscopy as described below. 
Platelets were labeled by incubating  individual grids in 20 pl of the FGN- 
Au or 10E5-Au suspension for 5 min at room temperature.  In control experi- 
ments, platelets were incubated  with albumin-labeled  colloidal gold, colloidal 
gold conjugated to the IgG fraction of normal serum, or with a large excess of 
soluble fibrinogen (2  mg/ml) before incubation  in the FGN-Au suspension. 
Grids were thoroughly washed in buffer to remove unbound label and processed 
for electron microscopy. 
Electron Microscopy:  All  samples  were  fixed in  0.1  M  HEPES 
buffered 1% glutaraldehyde, 0.2% tannic  acid, 0.05% Saponin, pH 7.2, for 30 
min at room temperature  (27). Specimens were postfixed in buffered 0.05% 
OsO4 for 20 min and stained in 1% UMgAc (aq.) for l0 min. Specimens were 
dehydrated  through a graded series of alcohol to absolute alcohol, itself dried 
by  storage  over  molecular  sieve.  Samples  were dried  by  the  critical  point 
procedure  in a critical point dryer equipped  with an in-line  molecular  sieve 
filter and a  hydrophobic  water-excluding filter.  Samples were evaporatively 
coated  with  a  thin  layer  of carbon and  stored  over  molecular  sieve until 
examined  with the AEI EM  7  l  MeV  electron  microscope  of the Madison 
HVEM facility. Stereo pair micrographs were taken  at tilt angles appropriate 
for specimen thickness and magnification  (18). Some samples were evapora- 
tively or sputter coated with -10 nm of gold or gold palladium  and examined 
on a JEOL JSM 35C scanning electron microscope at 10-20 kV accelerating 
voltage. A tilt angle of 7* was used for SEM stereo pairs. 
The number of FGN-Au labels bound per platelet at saturation  was deter- 
mined  by direct  counting of labels on  individual  platelets.  Micrographs  of 
randomly selected well spread platelets from three separate experiments were 
enlarged  to  a  final  print  magnification  of  100,000.  Individual  labels  were 
counted and marked on a transparent  overlay. 
RESULTS 
Fibrinogen-labeled  colloidal  gold  is  a  suitable  particulate 
marker for the detection and localization of the platelet mem- 
brane  receptor for fibrinogen  by  both  scanning  and  high 
voltage electron microscopy. The individual FGN-Au labels 
are visible as discrete markers, relatively homogeneous in size 
and  shape  (Fig.  l).  Control  preparations,  those  in  which 
platelets were incubated with albumin-labeled colloidal gold, 
colloidal gold conjugated to the IgG fraction of normal serum, 
or with an excess of soluble fibrinogen before incubation with 
FGN-Au, lacked significant labeling. 
FIGURE  1  Individual  FGN-Au  labels  on  the  surface  of a  human 
platelet as seen  by scanning electron  microscopy.  Bar, 0.1  pm.  × 
35,500. 
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sion, minimal spreading of the hyalomere produces charac- 
teristically dendritic shaped platelets possessing  several long 
thin pseudopodia.  During this stage  of spreading,  FGN-Au 
labels are present in limited numbers (Fig. 2). There is a rapid, 
marked increase in the amount of  FGN-Au bound per platelet 
as spreading proceeds as illustrated in Fig. 3. FGN-Au labels 
are distributed uniformly over the entire surface of platelets 
including the pseudopodia. The binding of fibrinogen contin- 
ues to increase during the  intermediate stages  of spreading 
(Fig. 4). Further extension of the cytoplasm produces larger, 
more oval platelets that possess numerous short pseudopodia. 
During this stage, FGN-Au labels remain evenly distributed; 
however, the labels are generally absent from the majority of 
the  pseudopodia.  Platelets  in  the  end  stages  of spreading 
possess a flattened, predominately round to oval shape with 
a raised granulomere area (Figs. 5 and 6). No further increase 
in the amount of fibrinogen bound per platelet occurs; how- 
ever, a  centralization of the FGN-Au levels  is seen.  In this 
well spread form, which represents saturation of  the fibrinogen 
FIGURE 2  Platelets in  the  initial stages of the spreading  process 
following adhesion.  Platelets  possess several  long pseudopodia. 
Few FGN-Au labels (arrows) are present. Bar, 1 #m. x  9,100. 
receptor, there are 7,600 +_ 500 labels per platelet. These labels 
are  found  primarily  overlying the  central  regions  of well 
spread platelets while the peripheral areas are relatively free 
of labels  (Fig.  5). In very late forms of spread platelets, this 
centralization is pronounced with labels tightly clustered over 
the central areas (Fig. 6). 
Whole mount preparations of  unlabeled platelets in the well 
spread form show the presence of four distinct ultrastructural 
zones (23). The cytoskeleton underlying each of these zones 
is exposed following Triton X-100 detergent extraction (Fig. 
7). HVEM examination of labeled, well spread platelets re- 
veals  the  same  binding  pattern  seen  by scanning  electron 
microscopy on platelets during the same stage. FGN-Au labels 
are  found  clustered  over the  inner  filamentous zone  and 
granulomere while absent from the peripheral web and outer 
filamentous zone (Fig. 8). The sharp delineation of the fibrin- 
ogen labels  corresponds to  the  transition  from the  loosely 
woven array of filaments in the outer filamentous zone to the 
more homogeneous "trabecular-like" inner filamentous zone. 
Well spread platelets labeled with the monoclonal antibody- 
gold conjugate directed against the IIb-IIIa glycoprotein com- 
plex (fibrinogen-receptor) demonstrated  the  same  receptor 
distribution (Fig. 9). 
DISCUSSION 
In  this  study, we  used  FGN-Au  to  illustrate the temporal 
changes in the amount of fibrinogen bound per platelet and 
the redistribution of the fibrinogen receptor during the acti- 
vation process of human platelets. The binding of FGN-Au 
to  the  fibrinogen receptor is  specific,  saturable,  and  time- 
dependent.  FGN-Au binding is  minimal  during the  initial 
stages of  adhesion and activation that is consistent with results 
from radiolabeling studies reported by others that show that 
while non-stimulated platelets in suspension fail to bind fi- 
brinogen there is a rapid increase in the amount of fibrinogen 
bound per platelet following stimulation by ADP or epineph- 
rine (3,  24,  26,  41).  After surface activation, the normally 
discoid  platelets  undergo  a  well  documented  sequence  of 
morphological changes including formation of pseudopodia, 
spreading of the hyalomere, and granule release (2,  50,  51). 
The  binding  of FGN-Au  to  surface-activated platelets  in- 
FIGURE 3  Platelet in pseudopodial stage  of spreading. The number of FGN-Au labels bound has increased significantly over the 
number present in Fig. 2. Labels  are uniformly distributed over the membrane including the pseudopodia (arrows). Bar, 1 pro. x 
7,900. 
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some pseudopodia (arrows); however, the majority of pseudopodia lack labels. Bar,  1 /~m. x  8,200. 
FIGURE  5  Platelet in the  late stage of spreading has a  more rounded shape with few pseudopodia. FGN-Au  labels are found 
predominately over the central areas while the peripheral areas possess few labels. Bar,  I  #m. x  8,200. 
FIGURE  6  Platelet in a very late stage of spreading illustrating the marked redistribution of the fibrinogen receptors to the central 
region of the platelet. A wide peripheral band is free of labels. Bar,  1 #m. x  10,300. 
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and rapidly reaches saturation. The number of labels present 
on the platelets after saturation is less than the mean number 
of receptors as calculated by Scatchard analysis for platelets 
in  suspension (3,  25,  41) for several reasons. The calcium- 
dependent GPIIa-IIIb complex has an apparent Stokes radius 
of 7.1 nm as calculated by Jennings and Phillips (20). With a 
mean size of 30 nm (gold granule +  fibrinogen exclusive of 
FIGURE  7  HVEM whole mount. Triton-insoluble cytoskeleton of a 
well spread  platelet. The peripheral web (PW) consists of a dense 
meshwork  of  filaments.  Filaments  in  the  outer  filamentous  zone 
(OF)  are  present within  a  loosely woven array while those within 
the  inner filamentous (IF) zone are very densely packed and  sur- 
round the remains of the granulomere. (G).  Bar 1 p.m. x  12,155. 
conductive metal coating), a single FGN-Au label can cover 
several  individual  receptor  sites  depending  on  the  spatial 
orientation of the receptor complexes within the membrane 
following induction.  Steric  hinderance  might  also  inhibit 
binding of the label to discrete receptor sites.  The adhesive 
face of  the platelet must also be considered. In certain cultured 
cell systems, cells are able to modulate their receptors away 
from the face in contact with the substrate towards the ex- 
posed upper surface (52).  It is  unknown whether adherent 
platelets are capable of this activity; if not, it is possible that 
a  number  of receptors  remain  on  the  adhesive  face  and 
unavailable for binding. 
Nonactivated platelets and platelets in the initial stages of 
adhesion lack fibrinogen labels. Small numbers of labels first 
appear during the  early pseudopodial  stage.  The  maximal 
binding of fibrinogen occurs during the  late  pseudopodial 
stage when the platelet cytoskeleton consists of a homogene- 
ous network of microfilaments throughout the cytoplasm and 
microfilament bundles  that  extend  into  the  pseudopodia. 
After maximal binding of fibrinogen, the receptors become 
centrally located.  The  receptors are  cleared  first  from the 
pseudopodia followed by peripheral regions in a progressive 
process. Centralization of  the fibrinogen receptor is coincident 
with the development of  the four distinct ultrastructural zones 
present only in well spread platelets (1,  23).  Platelets in the 
pseudopodial  stages,  which  possess  uniform  labeling,  lack 
these distinct structural zones, which suggests that reorgani- 
zation of contractile cytoskeleton elements may play a major 
role in receptor movement. Pollard et al.  (42),  Debus et al. 
(10),  and  Painter and  Ginsberg (35)  have shown,  through 
immunofluorescent techniques, there is  a  redistribution  of 
myosin  during  platelet  spreading.  Myosin  is  initially  uni- 
formly distributed throughout the  cytoplasm but  becomes 
more centralized in stimulated platelets. The same authors 
also show a high concentration ofactin in platelet pseudopods, 
while in later stages the actin distribution appears more uni- 
FIGURE  8  HVEM whole mount.  Platelet in a similar stage of spreading as that in Fig.  6.  FGN-Au  labels are found overlying the 
inner  filamentous  (IF) and  granulomere  (G)  zones while  labels  are  nearly absent  from  the  outer  filamentous  (OF)  zone  and 
peripheral web (PW).  Stereo imaging reveals that the background  labels are on the backside of the Formvar film.  Bar,  I  p.m.  x 
15,000. 
826  THE  JOURNAL  OF  CELL  BIOLOGY  • VOLUME  99,  1984 FIGURE  9  HVEM  whole mount. Well spread platelet labeled with colloidal gold conjugated to a antibody directed against the 
GP lib-Ilia receptor complex. Labels exhibit the same centralized distribution as the FGN-Au labels in Fig. 8. Bar, 1 /~m. x  11,800. 
form. This is consistent with our findings demonstrating actin 
bundles in pseudopods while in the later fully spread forms, 
actin filaments are seen both in the outer filamentous zone 
and in somewhat higher density in the peripheral web and in 
the inner filamentous zone that surrounds the granulomere 
(23). This segregation could provide the mechanism for force 
generation and directed movement inward of receptors. The 
sharp delineation between the outer and inner zones together 
with the nearly exclusive localization of FGN-Au labels over 
the  inner filamentous zone suggests  a  mechanism in which 
the receptor glycoproteins are linked to the reorganizing cy- 
toskeletal elements. 
With  respect to the centralized receptor redistribution  in 
the fully spead platelets, it is possible the fibrinogen receptors 
are simply being restrained in the membrane at their site of 
formation while receptor free membrane continues to spread 
outward as the spreading process proceeds. However, a mech- 
anism involving receptor redistribution based on movement 
within the plane of the membrane is perhaps more likely for 
the following reasons. First, if receptors are simply restrained 
in the membrane, pseudopodial labeling patterns should be 
retained in well spread platelets that are formed by outward 
membrane  flow  into  the  area  between  pseudopods.  These 
patterns are  never observed in  well  spread forms.  Second, 
many labeled receptor sites are at a greater distance from the 
center of the  platelet in  early spreading forms than in  well 
spread forms. This is particularly true of the early pseudopo- 
dial stage, in which labels are found far out on the pseudo- 
podia. This distance is greater than the distance at which the 
farthest labels are found in the very late stage spread platelet 
in  which  all  labels  are  tightly  packed  in  the  smaller area 
underlaid by the inner filamentous zone of the cytoskeleton. 
Third, in  preliminary studies, in which well spread platelets 
are lightly fixed, then labeled with the monoclonal antibody 
directed against the glycoprotein lib-Ilia receptor complex, 
receptors are not found tightly clustered over the central area 
as  when  living  platelets  are  labeled,  but  rather  are  found 
predominantly over peripheral regions including the periph- 
eral web. This data and its implications with respect to the 
movement of occupied and unoccupied receptor complexes 
will be considered in more detail in a  manuscript now in a 
preparation. 
Further evidence that supports the interaction of the fibrin- 
ogen receptor with cytoskeletal elements comes from studies 
involving platelet-membrane glycoproteins that have identi- 
fied GPIIb and GPIIIa as the specific components that com- 
plex  with  fibrinogen  (32).  Both  glycoproteins  are  integral 
proteins of the platelet membrane and are solubilized only by 
detergent disruption of the membrane (4). Furthermore, both 
glycoproteins apparently span  the  membrane since  neither 
one is affected by thrombin treatment of intact platelets, yet 
both are hydrolyzed by thrombin treatment of  isolated platelet 
membranes (38). Biochemical studies have also demonstrated 
these glycoproteins to be directly associated with  the  cyto- 
skeleton. Phillips and Agin (39) reported that the amounts of 
GPIIb and GPIIIa were selectively increased in the Triton X- 
100  residues  from thrombin  aggregated platelets,  while the 
amounts in Triton X- 100 residues from unstimulated platelets 
are  not  significantly above background  levels.  Painter and 
Ginsberg (36) reported that concanavalin A induces a linkage 
of GPIIa and GPIIIb to Triton  X-100-insoluble structures, 
and under conditions that promote the depolymerization of 
actin, both glycoproteins were released  from the Triton  X- 
100 residue indicating a  direct association with actin. Other 
mechanisms,  some  involving actin  binding  proteins  as  an 
intermediate between glycoproteins and actin, have also been 
proposed (11, 40). The signal for centralization of these recep- 
tor glycoproteins is generated following their interaction with 
the  natural  ligand  or with  antibody  since  the  gold-labeled 
monoclonal antibodies directed against the  nonligand filled 
GPIIb-IIIa  receptor complex exhibited a similar receptor dis- 
tribution pattern to FGN-Au on platelets in the end stages of 
activation. 
The mechanism through which receptor-bound fibrinogen 
mediates aggregation is unknown. While a reduction of sur- 
face charge after fibrinogen binding (44)  may facilitate the 
association of membrane components on adjacent platelets, 
it has also been proposed that the cross-linking of exposed 
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a more important role (15,  19,  34). Similarly, platelet-fibrin- 
ogen bridges are of probable importance in clot retraction. A 
model proposed by  Cohen (5,  6)  relies  upon the extension 
and retraction of pseudopods bound to fibrin to gather fibrin 
strands into the developing platelet-fibrin clumps. This would 
be the case in the pseudopodial stages in which we have shown 
the  fibrinogen  receptors  to  be  distributed  over  the  entire 
membrane  including  the  pseudopodia.  The  subsequent  in- 
ward movement of receptors with attacked fibrinogen (fibrin) 
strands provides a mechanism whereby linked adjacent plate- 
lets  would  be  drawn  closer together and  could  overlap.  In 
support  of  this  mechanism,  R.  D.  Allen  and  co-workers 
(personal  communication) have  observed  strands  of fibrin 
extending out radially from areas corresponding to the inner 
filamentous and granulomere zones platelets to similar areas 
on adjacent fully spread platelets. This mechanism is consist- 
ent with the abnormalities both in platelet aggregation and in 
clot retraction seen in thrombasthenic patients whose platelets 
lack the fibrinogen receptor. 
A more precise localization of myosin with respect to actin 
and the exact nature of the receptor-cytoskeleton link remains 
to be  determined  as does  the distribution,  movement, and 
interaction with the other receptor glycoproteins important 
in  platelet  function.  Considering  the  size  of  the  receptor 
complexes and the number of various different receptors thus 
far described, the ratio of receptors/surface area in the platelet 
is extremely high  when compared with most nucleated cell 
types. Thus, spatial factors may prove to be very important. 
The movement, concentration, and surface area occupied by 
the fibrinogen receptor, as demonstrated in the present study, 
has to be considered in the context of numerous other receptor 
molecules also  located  on  the  platelet  surface and  possibly 
associated with the platelet cytoskeleton. The availability of 
receptors may depend not only on the presence of an active 
receptor on the platelet surface but on whether or not steric 
blocking of this receptor by adjacent other types of receptors 
or receptor-ligand complexes occurs. In the latter situation, it 
will be of particular interest to determine if a "first come, first 
served" strategy is employed with respect to ligand, or if some 
method of ensuring a supply of unblocked receptors, for some 
or all ligand types, is at work, such as sequential presentation 
or surface compartmentalization. 
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